Cliff Asness's AZN Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 55,980 shares of AstraZeneca PLC (AZN) worth $10.29 M, representing 0.01% of the portfolio. First purchased in 2014-Q2, this medium-term investment has been held for 12 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in AZN, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 15,420 shares. Largest reduction occurred in Q3 2014, reducing 1.19 M shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's AstraZeneca PLC (AZN) Holding Value Over Time
Track share changes against reported price movement
Quarterly AstraZeneca PLC (AZN) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +13,588 | Add 32.05% | 55,980 | $183.86 |
| Q3 2025 | +15,420 | Add 57.17% | 42,392 | $153.44 |
| Q2 2025 | +8,222 | Add 43.85% | 26,972 | $139.76 |
| Q1 2025 | +5,844 | Add 45.28% | 18,750 | $147.00 |
| Q4 2024 | +3,474 | Add 36.83% | 12,906 | $131.03 |
| Q3 2024 | +2,590 | Add 37.85% | 9,432 | $155.82 |
| Q2 2024 | +3,620 | Add 112.35% | 6,842 | $156.00 |
| Q1 2024 | +670 | Add 26.25% | 3,222 | $135.50 |
| Q4 2023 | +182 | Add 7.68% | 2,552 | $134.67 |
| Q3 2023 | +2,370 | New Buy | 2,370 | $135.44 |
| Q3 2014 | -1.19 M | Sold Out | 0 | $0.00 |
| Q2 2014 | +1.19 M | New Buy | 1.19 M | $74.31 |
Cliff Asness's AstraZeneca PLC Investment FAQs
Cliff Asness first purchased AstraZeneca PLC (AZN) in Q2 2014, acquiring 1,186,418 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held AstraZeneca PLC (AZN) for 12 quarters since Q2 2014.
Cliff Asness's largest addition to AstraZeneca PLC (AZN) was in Q2 2014, adding 1,186,418 shares worth $88.16 M.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 55,980 shares of AstraZeneca PLC (AZN), valued at approximately $10.29 M.
As of the Q4 2025 filing, AstraZeneca PLC (AZN) represents approximately 0.01% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in AstraZeneca PLC (AZN) was 1,186,418 shares, as reported at the end of Q2 2014.